Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Xiao, Fengxia ^a   Zimpelmann, Joseph ^a   Agaybi, Samih ^a   Gurley, Susan B ^b   Puente, Lawrence ^c   Burns, Kevin D ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; GLUCOSE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DEGLYCOSYLATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME GLYCOSYLATION; ENZYME INHIBITION; ENZYME RELEASE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KIDNEY TUBULE CELL; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTEIN FUNCTION; RECEPTOR BINDING;

ADAM PROTEINS; AMINO ACID SEQUENCE; ANGIOTENSIN II; ANIMALS; CATALYTIC DOMAIN; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; GLUCOSE; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PEPTIDYL-DIPEPTIDASE A; PRIMARY CELL CULTURE; PROTEOLYSIS;

EID: 84898623111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085958     Document Type: Article

References (30)

1. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, et al.(2000) A novel angiotensin-converting enzyme-related carboxypeptidase(ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-9
2. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, et al.(2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243
3. Ye M, Wysocki J, Naaz P, Salabat MR, LaPointe MS, et al.(2004) Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 43: 1120-1125 (Pubitemid 38579924)
4. Li N, Zimpelmann J, Cheng K, Wilkins JA, Burns KD(2005) The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol 288: F353-362 (Pubitemid 40105394)
5. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, et al.(2006) Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin IIdependent glomerulosclerosis. Am J Pathol 168: 1808-1820 (Pubitemid 43825302)
6. Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, et al.(2007) Loss of angiotensin-converting enzyme-2(Ace2) accelerates diabetic kidney injury. Am J Pathol 171: 438-451 (Pubitemid 47344677)
7. Oudit GY, Liu GC, Zhong J, Basu R, Chow FL, et al.(2010) Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59: 529-538
8. Nadarajah R, Milagres R, Dilauro M, Gutsol A, Xiao F, et al.(2012) Podocytespecific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int 82: 292-303
9. Reich HN, Oudit GY, Penninger JM, Scholey JW, Herzenberg AM(2008) Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int 74: 1610-1616
10. Ye M, Wysocki J, William J, Soler MJ, Cokic I, et al.(2006) Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin- converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 17: 3067-3075 (Pubitemid 44707767)
11. Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, et al.(2005) Tumor necrosis factor-Alpha convertase(ADAM17) mediates regulated ectodomain shedding of the severe-Acute respiratory syndrome-coronavirus(SARS-CoV) receptor, angiotensin-converting enzyme-2(ACE2). J Biol Chem 280: 30113-30119 (Pubitemid 41216188)
12. Iwata M, Silva Enciso JE, Greenberg BH(2009) Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme. Am J Physiol Cell Physiol 297: C1318-1329
13. Jia HP, Look DC, Tan P, Shi L, Hickey M, et al.(2009) Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am J Physiol Lung Cell Mol Physiol 297: L84-96
14. Warner FJ, Lew RA, Smith AI, Lambert DW, Hooper NM, et al.(2005) Angiotensin-converting enzyme 2(ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J Biol Chem 280: 39353-39362 (Pubitemid 41713892)
15. Wysocki J, Garcia-Halpin L, Ye M, Maier C, Sowers K, et al.(2013) Regulation of Urinary ACE2 in Diabetic Mice. Am J Physiol Renal Physiol 305: F600-F611
16. Mizuiri S, Aoki T, Hemmi H, Arita M, Sakai K, et al.(2011) Urinary angiotensin-converting enzyme 2 in patients with CKD. Nephrology(Carlton) 16: 567-572
17. Xiao F, Hiremath S, Knoll G, Zimpelmann J, Srivaratharajah K, et al.(2012) Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes. PLoS One 7: e37649
18. Park SE, Kim WJ, Park SW, Park JW, Lee N, et al.(2013) High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria. Eur J Endocrinol 168: 203-210
19. Chodavarapu H, Grobe N, Somineni HK, Salem ES, Madhu M, et al.(2013) Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion. PLoS One 8: e62833
20. Vinay P, Gougoux A, Lemieux G(1981) Isolation of a pure suspension of rat proximal tubules. Am J Physiol 241: F403-411
21. Ye M, Wysocki J, Gonzalez-Pacheco FR, Salem M, Evora K, et al.(2012) Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin IIdependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2. Hypertension 60: 730-740
22. Kassiri Z, Oudit GY, Kandalam V, Awad A, Wang X, et al.(2009) Loss of TIMP3 enhances interstitial nephritis and fibrosis. J Am Soc Nephrol 20: 1223-1235
23. Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD(2010) Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am J Physiol Renal Physiol 298: F1523-1532
24. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M(2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1: 2856-2860
25. Freour T, Jarry A, Bach-Ngohou K, Dejoie T, Bou-Hanna C, et al.(2009) TACE inhibition amplifies TNF-Alpha-mediated colonic epithelial barrier disruption. Int J Mol Med 23:41-48
26. Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, et al.(2000) Functional analysis of the domain structure of tumor necrosis factor-Alpha converting enzyme. J Biol Chem 275: 14608-14614 (Pubitemid 30339751)
27. Fan H, Turck CW, Derynck R(2003) Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-Alpha converting enzyme and of an alternatively translated polypeptide. J Biol Chem 278: 18617-18627 (Pubitemid 36799489)
28. Lai ZW, Hanchapola I, Steer DL, Smith AI(2011) Angiotensin-converting enzyme 2 ectodomain shedding cleavage-site identification: determinants and constraints. Biochemistry 50: 5182-5194
29. Caescu CI, Jeschke GR, Turk BE(2009) Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem J 424: 79-88
30. Maluf-Meiken LC, Fernandes FB, Aragao DS, Ronchi FA, Andrade MC, et al.(2012). N-domain isoform of Angiotensin I converting enzyme as a marker of hypertension: populational study. Int J Hypertens 2012: 58170.